Sufentanilum [Inn-Latin] en es it fr

Sufentanilum [Inn-Latin] Brand names, Sufentanilum [Inn-Latin] Analogs

Sufentanilum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Sufentanilum [Inn-Latin] Chemical_Formula


Sufentanilum [Inn-Latin] RX_link

No information avaliable

Sufentanilum [Inn-Latin] fda sheet

Sufentanilum [Inn-Latin] msds (material safety sheet)

Sufentanilum_[Inn-Latin] MSDS

Sufentanilum [Inn-Latin] Synthesis Reference

No information avaliable

Sufentanilum [Inn-Latin] Molecular Weight

386.552 g/mol

Sufentanilum [Inn-Latin] Melting Point

97 oC

Sufentanilum [Inn-Latin] H2O Solubility

76 mg/L

Sufentanilum [Inn-Latin] State


Sufentanilum [Inn-Latin] LogP


Sufentanilum [Inn-Latin] Dosage Forms

Liquid; Solution

Sufentanilum [Inn-Latin] Indication

Used as an analgesic adjunct in anesthesia and as a primary anesthetic drug in procedures requiring assisted ventilation and in the relief of pain.

Sufentanilum [Inn-Latin] Pharmacology

Sufentanil is a synthetic opioid analgesic. Sufentanil interacts predominately with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, spinal cord, and other tissues. In clinical settings, sufentanil exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Sufentanil may increase the patient's tolerance for pain and decrease the perception of suffering, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Sufentanil depresses the respiratory centers, depresses the cough reflex, and constricts the pupils.

Sufentanilum [Inn-Latin] Absorption

No information avaliable

Sufentanilum [Inn-Latin] side effects and Toxicity

LD50: 18.7 mg/kg (IV in mice)

Sufentanilum [Inn-Latin] Patient Information

Sufentanilum [Inn-Latin] Organisms Affected

Humans and other mammals